Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Serum milk fat globule-EGF factor 8 protein as a potential biomarker for metabolic syndrome

Han Ah Lee, Jihwan Lim, Hyung Joon Joo, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Yoon Tae Jeen, Jong Eun Yeon, Do-Sun Lim, Kwan Soo Byun, Yeon Seok Seo

Clin Mol Hepatol. 2021;27(3):463-473. Published online February 15, 2021

DOI: https://doi.org/10.3350/cmh.2020.0351

View: 5958 Download: 169 Web of Science: 2 Crossref: 2

Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis

Dae Hoe Gu, Moon Young Kim, Yeon Seok Seo, Sang Gyune Kim, Han Ah Lee, Tae Hyung Kim, Young Kul Jung, Altay Kandemir, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um

Clin Mol Hepatol. 2018;24(3):319-330. Published online April 30, 2018

DOI: https://doi.org/10.3350/cmh.2017.0077

View: 12021 Download: 404 Web of Science: 88 Crossref: 89

Cyanoacrylate injection versus band ligation for bleeding from cardiac varices along the lesser curvature of the stomach

Sang Jung Park, Yong Kwon Kim, Yeon Seok Seo, Seung Woon Park, Han Ah Lee, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jae Young Jang, Jong Eun Yeon, Kwan Soo Byun

Clin Mol Hepatol. 2016;22(4):487-494. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0050

View: 9371 Download: 152 Web of Science: 11 Crossref: 10

Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B

Han Ah Lee, Yeon Seok Seo, Seung Woon Park, Sang Jung Park, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um

Clin Mol Hepatol. 2016;22(3):382-389. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0047

View: 12520 Download: 201 Web of Science: 18 Crossref: 19

1 |

Viewed By 4932	MAFLD: How is it different from NAFLD?
Viewed By 4828	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4724	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4444	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4402	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 94	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search